Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dupixent
Pharma
FDA approves 2nd indication for Amgen, AstraZeneca's Tezspire
The FDA has endorsed Amgen and AstraZeneca’s Tezspire for patients age 12 and older with chronic rhinosinusitis with nasal polyps.
Kevin Dunleavy
Oct 17, 2025 5:12pm
AZ's Fasenra flunks COPD trial as Saphnelo makes grade in lupus
Sep 17, 2025 11:47am
Issues at Novo Nordisk’s Indiana site trip up Regeneron again
Aug 1, 2025 11:51am
Sanofi doesn't expect drug tariffs to weigh on its 2025 guidance
Jul 31, 2025 1:21pm
GSK holds to its £40B projection for 2031, despite Blenrep woes
Jul 30, 2025 11:05am
The top 10 pharma drug ad spenders of 2024
Jun 30, 2025 3:00am
